Compare DIN & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIN | CLPT |
|---|---|---|
| Founded | 1958 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.8M | 467.9M |
| IPO Year | 1994 | 2009 |
| Metric | DIN | CLPT |
|---|---|---|
| Price | $35.00 | $16.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $29.00 | $20.00 |
| AVG Volume (30 Days) | 239.2K | ★ 571.2K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.78% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $879,300,000.00 | $36,971,000.00 |
| Revenue This Year | $3.61 | $45.67 |
| Revenue Next Year | $0.64 | $19.51 |
| P/E Ratio | $39.26 | ★ N/A |
| Revenue Growth | 8.25 | ★ 17.78 |
| 52 Week Low | $22.38 | $8.27 |
| 52 Week High | $39.68 | $30.10 |
| Indicator | DIN | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 53.10 |
| Support Level | $33.50 | $13.25 |
| Resistance Level | $36.99 | $16.54 |
| Average True Range (ATR) | 1.35 | 0.56 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 74.78 | 80.87 |
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.